26 /100
MEDIUM RISK
Score updated Jul 14, 2026

SURG — SurgePays, Inc. Dilution Risk Tracker

Track SURG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SURG — Get alerts when the score changes →

As of July 14, 2026, SurgePays, Inc. (SURG) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. SurgePays, Inc. has a market capitalization of $14.86M, 25.12M shares outstanding. Key dilution vectors include 70.0K outstanding warrants, approximately 31 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.64 below $1 exchange minimum
🔔 Track SURG — Get forecast alerts →

💹 Market Data

Market Cap$14.86M
Shares Outstanding25.12M
Float17.54M
Cash$12.06M
Debt$18.08M
Short InterestN/A

🏛 Institutional Holdings

8.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track SURG for full holder detail →

📉 Short Interest

Short Interest487.5K
Days to Cover3.0
% of Float2.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
xbrl XBRL WARRANT Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for SURG Shareholders

SurgePays, Inc. (SURG) has a DilutionScore of 26/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for SURG shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for SURG in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for SURG alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track SURG Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SURG — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for SURG
📊 SURG FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SURG Signal Convergence & Dark Pool Activity — StonkWhisper 📄 SURG Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.